Specification
Overview
Product Name
HMGB1 Recombinant Rabbit Monoclonal Antibody [SA39-03]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human HMGB1 aa 151-200 / 215.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, FC, IHC-Fr
Molecular Weight
Predicted band size: 25 kDa
Positive Control
HeLa, HepG2 cell lysate, HeLa cell lysate, HCT 116 cell lysate, A549 cell lysate, Jurkat cell lysate, C2C12 cell lysate, C6 cell lysate, Mouse thymus tissue lysate, Rat spleen tissue lysate, MCF-7, human kidney tissue, mouse brain tissue, mouse hippocampus tissue, rat brain tissue, rat hippocampus tissue, C2C12, C6, HCT 116.
Conjugation
unconjugated
Clone Number
SA39-03
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:20,000-1:50,000
-
IF-Cell
-
1:500
-
IF-Tissue
-
1:2,000
-
IHC-P
-
1:5,000-1:20,000
-
FC
-
1:1,000
-
IHC-Fr
-
1:500
Target
Function
High mobility group box 1 protein, also known as high-mobility group protein 1 (HMG-1) and amphoterin, is a protein that in humans is encoded by the HMGB1 gene. HMG-1 belongs to the high mobility group and contains a HMG-box domain. Like the histones, HMGB1 is among the most important chromatin proteins. In the nucleus HMGB1 interacts with nucleosomes, transcription factors, and histones. This nuclear protein organizes the DNA and regulates transcription. After binding, HMGB1 bends DNA, which facilitates the binding of other proteins. HMGB1 supports transcription of many genes in interactions with many transcription factors. It also interacts with nucleosomes to loosen packed DNA and remodel the chromatin. Contact with core histones changes the structure of nucleosomes. The presence of HMGB1 in the nucleus depends on posttranslational modifications. When the protein is not acetylated, it stays in the nucleus, but hyperacetylation on lysine residues causes it to translocate into the cytosol. HMGB1 has been shown to play an important role in helping the RAG endonuclease form a paired complex during V(D)J recombination.
Background References
1. "Novel role of PKR in inflammasome activation and HMGB1 release." Lu B., Nakamura T., Inouye K., Li J., Tang Y., Lundbaeck P., Valdes-Ferrer S.I., Olofsson P.S., Kalb T., Roth J., Zou Y., Erlandsson-Harris H., Yang H., Ting J.P., Wang H., Andersson U., Antoine D.J., Chavan S.S., Hotamisligil G.S., Tracey K.J. Nature 488:670-674(2012).
2. "The genetic variation of the human HMGB1 gene." Kornblit B., Munthe-Fog L., Petersen S., Madsen H., Vindeloev L., Garred P. Tissue Antigens 70:151-156(2007).
Sequence Similarity
Belongs to the HMGB family.
Tissue Specificity
Ubiquituous. Expressed in platelets.
Post-translational Modification
Phosphorylated at serine residues. Phosphorylation in both NLS regions is required for cytoplasmic translocation followed by secretion.; Acetylated on multiple sites upon stimulation with LPS. Acetylation on lysine residues in the nuclear localization signals (NLS 1 and NLS 2) leads to cytoplasmic localization and subsequent secretion (By similarity). Acetylation on Lys-3 results in preferential binding to DNA ends and impairs DNA bending activity (By similarity).; Reduction/oxidation of cysteine residues Cys-23, Cys-45 and Cys-106 and a possible intramolecular disulfide bond involving Cys-23 and Cys-45 give rise to different redox forms with specific functional activities in various cellular compartments: 1- fully reduced HMGB1 (HMGB1C23hC45hC106h), 2- disulfide HMGB1 (HMGB1C23-C45C106h) and 3- sulfonyl HMGB1 (HMGB1C23soC45soC106so).; Poly-ADP-ribosylated by PARP1 when secreted following stimulation with LPS (By similarity).; In vitro cleavage by CASP1 is liberating a HMG box 1-containing peptide which may mediate immunogenic activity; the peptide antagonizes apoptosis-induced immune tolerance. Can be proteolytically cleaved by a thrombin:thrombomodulin complex; reduces binding to heparin and proinflammatory activities (By similarity).
Subcellular Location
Cytoplasm, Nucleus, Cell membrane, Secreted, Chromosome
Synonyms
Amphoterin antibody
Chromosomal protein, nonhistone, HMG1 antibody
DKFZp686A04236 antibody
High mobility group 1 antibody
High mobility group box 1 antibody
High mobility group protein 1 antibody
High mobility group protein B1 antibody
high-mobility group (nonhistone chromosomal) protein 1 antibody
HMG-1 antibody
HMG1 antibody
ExpandAmphoterin antibody
Chromosomal protein, nonhistone, HMG1 antibody
DKFZp686A04236 antibody
High mobility group 1 antibody
High mobility group box 1 antibody
High mobility group protein 1 antibody
High mobility group protein B1 antibody
high-mobility group (nonhistone chromosomal) protein 1 antibody
HMG-1 antibody
HMG1 antibody
HMG3 antibody
HMGB 1 antibody
HMGB1 antibody
HMGB1_HUMAN antibody
NONHISTONE CHROMOSOMAL PROTEIN HMG1 antibody
SBP 1 antibody
Sulfoglucuronyl carbohydrate binding protein antibody
CollapseImages
-
Western blot analysis of HMGB1 on different lysates with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/50,000 dilution and competitor's antibody at 1/10,000 dilution.
Lane 1: HepG2 cell lysate
Lane 2: HeLa cell lysate
Lane 3: HCT 116 cell lysate
Lane 4: A549 cell lysate
Lane 5: Jurkat cell lysate
Lane 6: C2C12 cell lysate
Lane 7: C6 cell lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 25 kDa
Observed band size: 25 kDa
Exposure time: 21 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1601-2) at 1/50,000 dilution and competitor's antibody at 1/10,000 dilution were used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockout (KO)
Western blot analysis of HMGB1 with anti-HMGB1 antibody [SA39-03] (ET1601-2) at 1/50,000 dilution.
Lane 1: Wild-type Raw264.7 whole cell lysate.
Lane 2: HMGB1 knockout Raw264.7 whole cell lysate.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary Anti-HMGB1 antibody (ET1601-2, 1/50,000) and Anti-HSP90 antibody (ET1605-56, 1/10,000) were used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG H&L (HRP) Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
Cell lysate was provided by Ubigene Biosciences (Ubigene Biosciences Co., Ltd., Guangzhou, China). -
Western blot analysis of HMGB1 on different lysates with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/20,000 dilution.
Lane 1: HeLa cell lysate (20 µg/Lane)
Lane 2: HCT 116 cell lysate (20 µg/Lane)
Lane 3: A549 cell lysate (20 µg/Lane)
Lane 4: HepG2 cell lysate (20 µg/Lane)
Lane 5: Jurkat cell lysate (20 µg/Lane)
Lane 6: Mouse thymus tissue lysate (20 µg/Lane)
Lane 7: Rat spleen tissue lysate (30 µg/Lane)
Predicted band size: 25 kDa
Observed band size: 25 kDa
Exposure time: 3 minutes 10 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1601-2) at 1/20,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HeLa cells labeling HMGB1 with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/500 dilution and competitor's antibody at 1/250 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/500 dilution and competitor's antibody at 1/250 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of MCF-7 cells labeling HMGB1 with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.05% Triton X-100 in PBS for 20 minutes, and then blocked with 2% negative goat serum for 30 minutes at room temperature. Cells were then incubated with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/100 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/20,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-2) at 1/20,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse brain tissue with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/20,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-2) at 1/20,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse hippocampus tissue with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/20,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-2) at 1/20,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat brain tissue with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/20,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-2) at 1/20,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat hippocampus tissue with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/20,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-2) at 1/20,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunocytochemistry analysis of C2C12 cells labeling HMGB1 with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling HMGB1 with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HCT 116 cells labeling HMGB1.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1601-2, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Application: IF-Tissue
Species: Mouse
Site: brain
Sample: Paraffin-embedded section
Antibody concentration: 1/2,000 -
Application: IHC-Fr
Species: Mouse
Site: brain
Sample: Frozen section
Antibody concentration: 1/500
Antigen retrieval: Not required -
Western blot analysis of HMGB1 on Mouse HMGB1 recombinant protein with Rabbit anti-HMGB1 antibody (ET1601-2) at 1/1,000 dilution.
Lysates/proteins at 50 ng/Lane.
Exposure time: 59 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1601-2) at 1/1,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Suppression of endothelial cell PANoptosis: qingyi decoction targets the TMAO-HMGB1 pathway to mitigate lung injury in acute pancreatitis rats
Journal: Apoptosis
DOI: 10.1007/s10495-025-02212-y
IF: 8.1
Application: WB,IHC
Reactivity: Rat,Human
Publish date: 2026 Jan
-
Injury-environment interaction: microglial priming by mTBI creates vulnerability to subsequent stress via the HMGB1-RAGE axis
Journal: Brain, Behavior, And Immunity
DOI: 10.1016/j.bbi.2026.106273
IF: 7.6
Application: WB,IF
Reactivity: Mouse
Publish date: 2026 Jan
-
Berberine Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the AMPK-HMGB1-NF-κB Signaling Axis
Journal: Frontiers In Bioscience-Landmark
DOI: 10.31083/FBL45524
IF: 3.1
Application: WB
Reactivity: Mouse
Publish date: 2026 Jan
-
IMB5023: Dual suppression of microtubule assembly and STAT3 signaling overcomes chemoresistance and activates antitumor immunity
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2026.117812
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2026 Feb
-
Necroptosis mediated by FKBP5 in alveolar fibroblasts drives Pseudomonas aeruginosa-induced acute lung injury
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2026.116368
IF: 4.7
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Feb
-
Hesperidin-Loaded Nanoparticles Attenuate Pathological Angiogenesis in Oxygen-Induced Retinopathy by Modulating the Retinal Immune Microenvironment
Journal: ACS Biomaterials Science & Engineering
DOI: 10.1021/acsbiomaterials.5c01924
IF: 5.5
Application: WB
Reactivity:
Publish date: 2026 Feb
-
Teleost HMGB1 paralogues mediate protective autophagy by interacting with NOD2 and ATG16L1 and activating ROS/Akt/mTOR pathway against Aeromonas hydrophila infection
Journal: Fish & Shellfish Immunology
DOI: 10.1016/j.fsi.2025.110902
IF: 3.9
Application: WB
Reactivity: Carp
Publish date: 2025 Sept
-
Mito-Specific “Trojan Horse” Nanotherapy: Synergistic Antitumor Immunotherapy via Dual Modulation Mitochondrial Metabolism and Glycolysis
Journal: ACS Applied Nano Materials
DOI: 10.1021/acsnano.5c08486
IF: 16
Application: IF-cell
Reactivity: Mouse
Publish date: 2025 Oct
-
Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity
Journal: Autophagy
DOI: 10.1080/15548627.2025.2576619
IF: 14.3
Application: IF-cell,WB
Reactivity: Human
Publish date: 2025 Oct
-
Platform-based BST-2-targeted microbubbles enhance HIFU therapy and effectively inhibit prostate cancer residual growth
Journal: International Journal of Hyperthermia
DOI: 10.1080/02656736.2025.2511035
IF: 3
Application: IF
Reactivity: Mouse
Publish date: 2025 May
-
FKBP5 Mediates Alveolar Fibroblast Necroptosis During Acute Respiratory Distress Syndrome
Journal: Cell Proliferation
DOI: 10.1111/cpr.70075
IF: 5.6
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jun
-
Environmental enrichment attenuates social isolation-exacerbated postoperative cognitive dysfunction in aged mice via inhibition of RAGE-HMGB1 proinflammatory signaling.
Journal: Brain Research Bulletin
DOI: 10.1016/j.brainresbull.2025.111462
IF: 3.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
Spatiotemporal-Controlled Nanoagonists Triggered STING Activation for Cascade-Amplified Photothermal Metalloimmunotherapy
Journal: Biomacromolecules
DOI: 10.1021/acs.biomac.4c01774
IF: 5.4
Application: IF
Reactivity: Mouse
Publish date: 2025 Jul
-
Cascaded immunotherapy with implantable dual-drug depots sequentially releasing STING agonists and apoptosis inducers
Journal: Nature Communications
DOI: 10.1038/s41467-025-56407-7
IF: 14.7
Application: IF
Reactivity: Mouse
Publish date: 2025 Feb
-
A fusion of oncolytic viruses and bispecific T-cell engagers for triple negative breast cancer immunotherapy
Journal: Chemical Engineering Journal
DOI: 10.1016/j.cej.2025.160853
IF: 13.3
Application: IF
Reactivity: Mouse
Publish date: 2025 Feb
-
An Immune Nanoenhancer Revitalizes Chemotherapeutics to Tailor Tumor-Derived dsDNA for Anticancer Immunoengineering
Journal: Advanced Materials
DOI: 10.1002/adma.202516524
IF: 26.8
Application: IF
Reactivity: Mouse
Publish date: 2025 Dec
-
MEK inhibitor induces cardiac complications by preventing ZMYND8-mediated ubiquitination and proteasomal degradation of HMGB1
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2025.117660
IF: 5.6
Application: WB,IF
Reactivity: Mouse,Human
Publish date: 2025 Dec
-
Harnessing Membrane-Targeting Photosensitizers to Evoke Ferroptosis and Pyroptosis Dual-Modal Cell Death for Antitumor Therapy
Journal: Molecular Pharmaceutics
DOI: 10.1021/acs.molpharmaceut.5c01042
IF: 4.5
Application: IF
Reactivity: Mouse
Publish date: 2025 Aug
-
Triggering Pyroptosis by Doxorubicin-Loaded Multifunctional Nanoparticles in Combination with Decitabine for Breast Cancer Chemoimmunotherapy
Journal: Biological And Medical Applications Of Materials And Interfaces
DOI:
IF: 8.3
Application: IF
Reactivity: Human
Publish date: 2024 Oct
-
Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer
Journal: ACS Applied Materials & Interfaces
DOI: 10.1021/acsami.4c10404
IF: 8.3
Application:
Reactivity:
Publish date: 2024 Oct
-
Ursolic acid improves necroptosis via STAT3 signaling in intestinal ischemia/reperfusion injury
Journal: International Immunopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Jul
-
A Self-Cascade Oxygen-Generating Nanomedicine for Multimodal Tumor Therapy
Journal: Small
DOI: 10.1002/smll.202403523
IF: 13
Application:
Reactivity:
Publish date: 2024 Jul
-
Injectable alginate hydrogel promotes antitumor immunity through glucose oxidase and Fe3+ amplified RSL3-induced ferroptosis
Journal: Carbohydrate Polymers
DOI: 10.1016/j.carbpol.2023.121643
IF: 11.2
Application: IF-Cell
Reactivity: Mouse
Publish date: 2024 Feb
-
A sodium alginate-based injectable hydrogel system for locoregional treatment of colorectal cancer by eliciting pyroptosis and apoptosis
Journal: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2024.139345
IF: 7.7
Application: WB
Reactivity: Mouse
Publish date: 2024 Dec
-
EZH2/miR-142-3p/HMGB1 axis mediates chondrocyte pyroptosis by regulating endoplasmic reticulum stress in knee osteoarthritis
Journal: Chinese Medical Journal
DOI:
IF: 7.5
Application: WB
Reactivity: Human
Publish date: 2024 Dec
-
Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF‑κB Signaling Pathway
Journal: Journal Of Integrative Neuroscience
DOI:
IF: 2.5
Application: IHC-P,WB
Reactivity: Rat
Publish date: 2024 Aug
-
Targeting the MCP-GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma
Journal: Advanced Science
DOI: 10.1002/advs.202308208
IF: 14.3
Application: IF
Reactivity: Human
Publish date: 2024 Apr
-
Lipid–Polymer Hybrid Nanoparticles with Both PD-L1 Knockdown and Mild Photothermal Effect for Tumor Photothermal Immunotherapy
Journal: ACS Applied Materials & Interfaces
DOI:
IF: 9.5
Application: IF
Reactivity: Mouse
Publish date: 2023 Sept
-
Grass carp Il-2 promotes neutrophil extracellular traps formation via inducing ROS production and autophagy in vitro
Journal: Fish & Shellfish Immunology
DOI:
IF: 4.7
Application: IF
Reactivity: Grass carp
Publish date: 2023 Nov
-
mTOR signaling pathway regulates embryonic development and rapid growth of triploid crucian carp
Journal: Aquaculture Reports
DOI: 10.1016/j.aqrep.2023.101860
IF: 3.7
Application:
Reactivity: Mouse
Publish date: 2023 Nov
-
Reduced HMGB1 expression contributed to lapatinib-induced cutaneous injury
Journal: Research Square
DOI:
IF: NA
Application: WB
Reactivity: Human
Publish date: 2022 Mar
-
SARS-CoV-2 ORF3a induces RETREG1/FAM134B dependent reticulophagy and triggers sequential ER stress and inflammatory responses during SARS-CoV-2 infection
Journal: Autophagy
DOI:
IF: 16.016
Application: WB
Reactivity: Human
Publish date: 2022 Mar
-
Decreased HMGB1 expression contributed to cutaneous toxicity caused by lapatinib
Journal: Biochemical Pharmacology
DOI:
IF: 5.8
Application: WB
Reactivity: Human
Publish date: 2022 Jul
-
Ginsenoside Rh2 Inhibits NLRP3 Inflammasome Activation and Improves Exosomes to Alleviate Hypoxia-Induced Myocardial Injury
Journal: Frontiers In Immunology
DOI:
IF: 8.786
Application: WB
Reactivity: Rat
Publish date: 2022 Jul
-
Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib
Journal: Autophagy
DOI:
IF: 16.014
Application: IF
Reactivity: Mouse
Publish date: 2021 Aug
-
Mesenchymal Stem Cells Attenuate Diabetic Lung Fibrosis via Adjusting Sirt3-Mediated Stress Responses in Rats
Journal: Oxidative Medicine And Cellular Longevity
DOI: 10.1155/2020/8076105
IF: 5.076
Application: WB
Reactivity: Mouse
Publish date: 2020 Feb
Products with the same target and pathway
HMGB1 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
HMGB1 Recombinant Rabbit Monoclonal Antibody [SA39-03] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC,IHC-Fr
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
HMGB1 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
